Joint Formulary & PAD

Guideline Profile : Migraine (prevention)

Committee Recommendations (1)

The Surrey Heartlands Integrated Care System Area Prescribing Committee has agreed SERMOG-08 Migraine pathway

Guideline Profile

Indication :
Migraine (prevention)
Keywords :
migraine days, episodic, chronic
Brand Names Include :
Fremanezumab, Eptinezumab, Botulinum toxin A, Erenumab, Galcanezumab, Rimegepant
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
1